ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
International Journal of Medicinal Mushrooms
インパクトファクター: 1.423 5年インパクトファクター: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN 印刷: 1521-9437
ISSN オンライン: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v7.i3.160
pages 353-354

Molecular Systematics of Ganoderma: What Is Reishi?

Jean-Marc Moncalvo
Department of Natural History, Centre for Biodiversity and Conservation Biology, Royal Ontario Museum and Department of Botany, University of Toronto, 100 Queen's Park, Toronto, Ontario M5S 2C6, Canada

要約

Ganoderma is a very distinctive genus of white-rot polypore fungi that is primarily characterized by the formation of a double-walled, generally echinulate basidiospore. Most Ganoderma species are very variable macromorphologically and lack micromorphological distinctiveness. As a consequence, earlier taxonomic studies in the genus have created many synonymous names and have resulted in largely ambiguous species delimitation and identification systems, making species identification in the genus virtually impossible. Ganoderma strains used in oriental folk medicine refer to Reishi and have traditionally been labeled Ganoderma lucidum (W.Curt.: Fr.) P. Karst. in the scientific literature. However, there is now accumulative evidence that most species reported as G. lucidum in most of the pharmacological and phytopathological studies were wrongly identified.
G. lucidum was first described as Boletus lucidus by William Curtis in 1781 from a filbert plant (= Corylus avellana) in London, UK. Curtis's original collection (i.e., the type specimen) has been lost. The actual type is represented in a color plate, which is in agreement with the International Code of Botanical Nomenclature. However, the typified plate is of no use for providing cultural characteristics and genetic information that would be useful for distinguishing G. lucidum from the other British laccate Ganoderma.
Over the years, at least 166 laccate Ganoderma species have been described worldwide, of which at least 48 names were, at some point, considered to be synonyms of others. There is nevertheless a strong consensus about the true identity of G. lucidum among contemporary European mycologists. Molecular phylogenetic studies indicate that Ganoderma is a young genus in agreement with earlier morphological evidence as pointed out by the Norwegian mycologist Leif Ryvarden. DNA studies have shown that the G. lucidum species complex is composed of several species that can be difficult to distinguish from one another. These species include the European G. valesiacum Boud.; G. ahamdii Stey., described from Pakistan; North American G. tsugae Murrill and G. oregonense Murrill; and other taxa variously labeled G. resinaceum Boud., G. oerstedii Fr., and G. praelongum Murrill.
Recent genetic and biogeographic studies have indicated that most Ganoderma species are geographically restricted. G. lucidum is probably restricted to western parts of Europe, although its distribution range can possibly also include parts of Siberia and of north western regions of China. Based on molecular phylogenetic evidence, it appears that most collections labeled G. lucidum in North America do in fact best correspond to the taxon labeled G. resinaceum in Europe, whereas G. tsugae in North America is genetically very close to the “true” G. lucidum from Europe.
This leads to the question of what is the Oriental Reishi? A nonexhaustive molecular survey of taxa labeled G. lucidum in Asia, including strains commercially cultivated for the production of health tablets or teas, shows that this name has been largely misapplied and encompasses many distinct species.
Incorrect taxonomic identification of Ganoderma strains hampers comprehensive strategies for drug discovery as well as for monitoring and managing diseases caused by Ganoderma in woody crops and forest ecosystems. Both molecular phylogenies and morphological evidence indicate that Africa probably harbors the highest genetic and taxonomic diversity in the genus.


Articles with similar content:

Medicinal Uses of Fungi by New Zealand Maori People
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Peter Buchanan, Rebekah Fuller, Mere Roberts
GACOCA Formulation of East African Wild Mushrooms Show Promise in Combating Kaposi's Sarcoma and HIV/ AIDS
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Julius David Sumba
Ecology, Morphology, and Morphogenesis in Nature of Edible and Medicinal Mushroom Grifola frondosa (Dicks.: Fr.) S.F.Gray—Maitake (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.2, 2000, issue 3
Paul E. Stamets, Robert B. Cooper, Nian Lai Huang, Sheng-Hua Han, Alice W. Chen
Biology, Food, Medicinal, and Biotechnological Applications of the Tropical Mushroom Pleurotus tuberregium (Rumph.:Fr.) Singer
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Paul E. Stamets, Rytas Vilgalys, Omoanghe S. Isikhuemhen
Reflections on Changing Names and Related Nomenclatural Issues in Edible and Medicinal Mushrooms
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 1&2
David L. Hawksworth